Design, synthesis and biological evaluation of novel carbamodithioates as anti-proliferative agents against human cancer cells
作者:Xia Liu、Zhijun Wang、Rui Xie、Pingwah Tang、Qipeng Yuan
DOI:10.1016/j.ejmech.2018.07.038
日期:2018.9
number of carbamodithioate derivatives with benzenethiols (substituted or unsubstituted) (1l, 1m, 1n, 1o, 1q, 1s, 2l, 2n, 2p, 2q, 2r and 2s) were investigated for in vitro anti-proliferative activities against five cancer cell lines: SMMC-7721, A549, A375, HCT 116 and Hela. The carbamodithioate compounds (1l, 1m, 1n, 1o, 1q and 1s) derived from SFE and the carbamodithioate compounds (2l, 2n, 2p, 2q, 2r and
已成功合成了一系列新的
氨基
硫代
氨基甲酸酯化合物。通常,SFE和SFA与
苯硫酚(取代或未取代的)的所有
氨基乙二
硫醚衍
生物均比其母体化合物SFE和SFA表现出更高的抑制百分比。研究了许多具有
苯硫酚(取代或未取代)的
氨基甲酰胺基
氨基甲酸酯衍
生物(1l,1m,1n,1o,1q,1s,2l,2n,2p,2q,2r和2s)对五个癌细胞的体外抗增殖活性。线路:
SMMC-7721,A549,A375,HCT 116和Hela。衍生自SFE的
氨基
脲二
甲酸酯化合物(1l,1m,1n,1o,1q和1s)和
氨基
硫脲二
甲酸酯化合物(2l,2n,2p,2q,2r和2s源自SFA的)对
SMMC-7721和A549癌细胞比对其他癌细胞更敏感,因为它们的IC 50值明显较低。此外,它们显示出比其母体化合物SFE和SFE更强的抑制活性。进一步的研究表明,这些
硫代
氨基甲酰胺衍
生物抑制了
SMMC-7721的集落形成,并显着诱导了
SMMC-7721癌细胞的G2